| Year |
Citation |
Score |
| 2019 |
Gentile CM, Borovjagin AV, Richter JR, Jani AH, Wu H, Zinn KR, Warram JM. Genetic strategy to decrease complement activation with adenoviral therapies. Plos One. 14: e0215226. PMID 31026285 DOI: 10.1371/Journal.Pone.0215226 |
0.551 |
|
| 2018 |
Fancy RM, Kim H, Napier T, Buchsbaum DJ, Zinn KR, Song Y. Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells. Journal of Cellular Biochemistry. PMID 29663486 DOI: 10.1002/Jcb.26848 |
0.337 |
|
| 2018 |
Vaklavas C, Zinn KR, Samuel SL, Meng Z, Grizzle WE, Choi H, Blume SW. Translational control of the undifferentiated phenotype in ER‑positive breast tumor cells: Cytoplasmic localization of ERα and impact of IRES inhibition. Oncology Reports. PMID 29620220 DOI: 10.3892/Or.2018.6332 |
0.348 |
|
| 2018 |
Kasten BB, Oliver PG, Kim H, Fan J, Ferrone S, Zinn KR, Buchsbaum DJ.
Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models. International Journal of Molecular Sciences. 19. PMID 29561763 DOI: 10.3390/Ijms19040925 |
0.316 |
|
| 2017 |
Rosenthal E, Moore L, Tipirneni K, de Boer E, Stevens TM, Hartman YE, Carroll WR, Zinn KR, Warram JM. Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28446503 DOI: 10.1158/1078-0432.Ccr-16-2968 |
0.649 |
|
| 2017 |
Kasten BB, Arend RC, Katre AA, Kim H, Fan J, Ferrone S, Zinn KR, Buchsbaum DJ. B7-H3-targeted (212)Pb radioimmunotherapy of ovarian cancer in preclinical models. Nuclear Medicine and Biology. 47: 23-30. PMID 28104527 DOI: 10.1016/J.Nucmedbio.2017.01.003 |
0.345 |
|
| 2017 |
Fancy RM, Kim H, Zhou T, Zinn KR, Buchsbaum DJ, Song Y. Calmodulin Binding to Death Receptor 5-mediated Death-inducing Signaling Complex in Breast Cancer Cells. Journal of Cellular Biochemistry. PMID 28092099 DOI: 10.1002/Jcb.25882 |
0.327 |
|
| 2016 |
Tipirneni KE, Warram JM, Moore LS, Prince AC, de Boer E, Jani AH, Wapnir IL, Liao JC, Bouvet M, Behnke NK, Hawn MT, Poultsides GA, Vahrmeijer AL, Carroll WR, Zinn KR, et al. Oncologic Procedures Amenable to Fluorescence-guided Surgery. Annals of Surgery. PMID 28045715 DOI: 10.1097/Sla.0000000000002127 |
0.632 |
|
| 2016 |
Moore LS, Rosenthal EL, de Boer E, Prince AC, Patel N, Richman JM, Morlandt AB, Carroll WR, Zinn KR, Warram JM. Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 27830425 DOI: 10.1007/S11307-016-1022-1 |
0.661 |
|
| 2016 |
Moore LS, Rosenthal EL, Chung TK, de Boer E, Patel N, Prince AC, Korb ML, Walsh EM, Young ES, Stevens TM, Withrow KP, Morlandt AB, Richman J, Carroll WR, Zinn KR, et al. Characterizing the utilities and limitations of repurposing an open-field optical imaging device for fluorescence-guided surgery in head and neck cancer patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27587708 DOI: 10.2967/Jnumed.115.171413 |
0.639 |
|
| 2016 |
Vaklavas C, Grizzle WE, Choi H, Meng Z, Zinn KR, Shrestha K, Blume SW. IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 27460074 DOI: 10.1007/S13277-016-5161-4 |
0.328 |
|
| 2016 |
Kim H, Samuel SL, Lopez-Casas PP, Grizzle WE, Hidalgo M, Kovar J, Oelschlager DK, Zinn KR, Warram JM, Buchsbaum DJ. SPARC independent delivery of nab-paclitaxel without depleting tumor stroma in patient-derived pancreatic cancer xenografts. Molecular Cancer Therapeutics. PMID 26832793 DOI: 10.1158/1535-7163.Mct-15-0764 |
0.658 |
|
| 2016 |
Vaklavas C, Grizzle WE, Choi H, Meng Z, Zinn KR, Blume SW. Abstract 3037: Tumor cell death triggered by sustained IRES inhibition is a population-wide event involving a quorum-sensing mechanism in which putative tumor stem cells are eliminated along with their progeny Cancer Research. 76: 3037-3037. DOI: 10.1158/1538-7445.Am2016-3037 |
0.352 |
|
| 2015 |
Kim H, Buchsbaum DJ, Zinn KR. A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 26552657 DOI: 10.1007/S11307-015-0913-X |
0.427 |
|
| 2015 |
Rosenthal EL, Warram JM, de Boer E, Basilion JP, Biel MA, Bogyo M, Bouvet M, Brigman BE, Colson YL, DeMeester SR, Gurtner GC, Ishizawa T, Jacobs PM, Keereweer S, Liao JC, ... ... Zinn KR, et al. Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26449839 DOI: 10.2967/Jnumed.115.158915 |
0.633 |
|
| 2015 |
de Boer E, Samuel S, French DN, Warram JM, Schoeb TR, Rosenthal EL, Zinn KR. Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 26335283 DOI: 10.1007/S11307-015-0892-Y |
0.623 |
|
| 2015 |
Vaklavas C, Meng Z, Choi H, Grizzle WE, Zinn KR, Blume SW. Small molecule inhibitors of IRES-mediated translation. Cancer Biology & Therapy. 0. PMID 26177060 DOI: 10.1080/15384047.2015.1071729 |
0.315 |
|
| 2015 |
de Boer E, Warram JM, Tucker MD, Hartman YE, Moore LS, de Jong JS, Chung TK, Korb ML, Zinn KR, van Dam GM, Rosenthal EL, Brandwein-Gensler MS. In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas. Scientific Reports. 5: 10169. PMID 26120042 DOI: 10.1038/Srep10169 |
0.66 |
|
| 2015 |
Rosenthal EL, Warram JM, de Boer E, Chung TK, Korb ML, Brandwein-Gensler M, Strong TV, Schmalbach C, Morlandt A, Agarwal G, Hartman YE, Carroll W, Richman JS, Clemons L, Nabell LM, ... Zinn KR, et al. Safety and Tumor-specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 25904751 DOI: 10.1158/1078-0432.Ccr-14-3284 |
0.637 |
|
| 2015 |
Rosenthal EL, Warram JM, Bland KI, Zinn KR. The status of contemporary image-guided modalities in oncologic surgery. Annals of Surgery. 261: 46-55. PMID 25599326 DOI: 10.1097/Sla.0000000000000622 |
0.613 |
|
| 2015 |
Zinn KR, Korb M, Samuel S, Warram JM, Dion D, Killingsworth C, Fan J, Schoeb T, Strong TV, Rosenthal EL. IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 49-57. PMID 25080323 DOI: 10.1007/S11307-014-0773-9 |
0.642 |
|
| 2015 |
Rosenthal EL, Boer Ed, Zinn K, Dam Gv, Warram J. Abstract SY36-02: Visualizing cancer: Surgical navigation using targeted fluorescent imaging agents Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Sy36-02 |
0.704 |
|
| 2015 |
Vaklavas C, Meng Z, Choi H, Grizzle WE, Zinn KR, Blume SW. Abstract 4363: Selective modulation of IRES-mediated translation in malignant cells Cancer Research. 75: 4363-4363. DOI: 10.1158/1538-7445.Am2015-4363 |
0.312 |
|
| 2015 |
de Boer E, Samuel S, French DN, Warram JM, Schoeb TR, Rosenthal EL, Zinn KR. Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques Molecular Imaging and Biology. DOI: 10.1007/s11307-015-0892-y |
0.547 |
|
| 2014 |
Bhattacharyya S, Patel N, Wei L, Riffle LA, Kalen JD, Hill GC, Jacobs PM, Zinn KR, Rosenthal E. Synthesis and biological evaluation of panitumumab-IRDye800 conjugate as a fluorescence imaging probe for EGFR-expressing cancers. Medchemcomm. 5: 1337-1346. PMID 25431648 DOI: 10.1039/C4Md00116H |
0.431 |
|
| 2014 |
Nelson CA, Azure MT, Adams CT, Zinn KR. The somatostatin analog 188Re-P2045 inhibits the growth of AR42J pancreatic tumor xenografts. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 2020-5. PMID 25359879 DOI: 10.2967/Jnumed.114.140780 |
0.354 |
|
| 2014 |
Kim H, Samuel SL, Zhai G, Rana S, Taylor M, Umphrey HR, Oelschlager DK, Buchsbaum DJ, Zinn KR. Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer. Cancer Biology & Therapy. 15: 1053-60. PMID 25084100 DOI: 10.4161/Cbt.29183 |
0.421 |
|
| 2014 |
Richter JR, Mahoney M, Warram JM, Samuel S, Zinn KR. A dual-reporter, diagnostic vector for prostate cancer detection and tumor imaging. Gene Therapy. 21: 897-902. PMID 25056609 DOI: 10.1038/Gt.2014.68 |
0.641 |
|
| 2014 |
Warram JM, Sorace AG, Mahoney M, Samuel S, Harbin B, Joshi M, Martin A, Whitworth L, Hoyt K, Zinn KR. Biodistribution of P-selectin targeted microbubbles. Journal of Drug Targeting. 22: 387-94. PMID 24731055 DOI: 10.3109/1061186X.2013.869822 |
0.651 |
|
| 2014 |
Sorace AG, Korb M, Warram JM, Umphrey H, Zinn KR, Rosenthal E, Hoyt K. Ultrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer. Ultrasound in Medicine & Biology. 40: 755-64. PMID 24412168 DOI: 10.1016/J.Ultrasmedbio.2013.11.002 |
0.653 |
|
| 2014 |
Korb ML, Hartman YE, Kovar J, Zinn KR, Bland KI, Rosenthal EL. Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer. The Journal of Surgical Research. 188: 119-28. PMID 24360117 DOI: 10.1016/J.Jss.2013.11.1089 |
0.379 |
|
| 2014 |
Zhai G, Kim H, Sarver D, Samuel S, Whitworth L, Umphrey H, Oelschlager DK, Beasley TM, Zinn KR. Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and (1)H MR spectroscopy. Journal of Magnetic Resonance Imaging : Jmri. 39: 1588-94. PMID 24151215 DOI: 10.1002/Jmri.24319 |
0.39 |
|
| 2014 |
Kim H, Rigell CJ, Zhai G, Lee SK, Samuel SL, Martin A, Umphrey HR, Stockard CR, Beasley TM, Buchsbaum DJ, Li LS, Boothman DA, Zinn KR. Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 85-94. PMID 23836505 DOI: 10.1007/S11307-013-0665-4 |
0.401 |
|
| 2014 |
Adams CP, Nelson C, Azure M, Zinn K. Effect of rhenium Re188-P2045 on tumor growth in the AR42J rat pancreatic tumor xenograft nude mouse model. Journal of Clinical Oncology. 32: e15224-e15224. DOI: 10.1200/Jco.2014.32.15_Suppl.E15224 |
0.373 |
|
| 2014 |
Foster RC, Krell AM, Chung TK, Warram JM, Zinn KR, Rosenthal EL. Characterizing fluorescent imaging properties of antibodies conjugated to IRDye800CW for use in imaging of head and neck cancer Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8926. DOI: 10.1117/12.2044435 |
0.644 |
|
| 2014 |
Korb ML, Warram JM, Warren ME, Samuel SL, Zinn KR, Bland KI, Rosenthal EL. Defining the Detection Threshold for Optical Imaging in Surgical Resection Journal of the American College of Surgeons. 219: S128. DOI: 10.1016/J.Jamcollsurg.2014.07.305 |
0.607 |
|
| 2013 |
Sorace AG, Warram JM, Mahoney M, Zinn KR, Hoyt K. Enhancement of adenovirus delivery after ultrasound-stimulated therapy in a cancer model. Ultrasound in Medicine & Biology. 39: 2374-81. PMID 24063960 DOI: 10.1016/J.Ultrasmedbio.2013.07.017 |
0.646 |
|
| 2013 |
Rosenthal EL, Zinn KR. Putting numbers to fluorescent guided surgery. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 647-8. PMID 23836503 DOI: 10.1007/S11307-013-0662-7 |
0.31 |
|
| 2013 |
Day KE, Sweeny L, Kulbersh B, Zinn KR, Rosenthal EL. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 722-9. PMID 23715932 DOI: 10.1007/S11307-013-0652-9 |
0.342 |
|
| 2013 |
Day KE, Beck LN, Deep NL, Kovar J, Zinn KR, Rosenthal EL. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. The Laryngoscope. 123: 2681-9. PMID 23616260 DOI: 10.1002/Lary.24102 |
0.371 |
|
| 2013 |
Heath CH, Deep NL, Beck LN, Day KE, Sweeny L, Zinn KR, Huang CC, Rosenthal EL. Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 148: 982-90. PMID 23525846 DOI: 10.1177/0194599813482290 |
0.373 |
|
| 2013 |
Sorace AG, Saini R, Rosenthal E, Warram JM, Zinn KR, Hoyt K. Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy. Ieee Transactions On Ultrasonics, Ferroelectrics, and Frequency Control. 60: 281-9. PMID 23357902 DOI: 10.1109/Tuffc.2013.2564 |
0.698 |
|
| 2013 |
Day KE, Beck LN, Heath CH, Huang CC, Zinn KR, Rosenthal EL. Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma. Cancer Biology & Therapy. 14: 271-7. PMID 23298904 DOI: 10.4161/Cbt.23300 |
0.442 |
|
| 2013 |
Saini R, Sorace AG, Warram JM, Mahoney MJ, Zinn KR, Hoyt K. An animal model allowing controlled receptor expression for molecular ultrasound imaging. Ultrasound in Medicine & Biology. 39: 172-80. PMID 23122640 DOI: 10.1016/J.Ultrasmedbio.2012.08.016 |
0.672 |
|
| 2013 |
Korb M, Hartman Y, Zinn K, Rosenthal E. Cetuximab-IRDye800 Bioconjugate to Image Breast Cancer in a Preclinical Xenograft Model Journal of Surgical Research. 179: 340. DOI: 10.1016/J.Jss.2012.10.793 |
0.394 |
|
| 2013 |
Korb ML, Hartman YE, Zinn KR, Bland KI, Rosenthal EL. Use of near-infrared imaging to improve surgical resection of breast cancer Journal of the American College of Surgeons. 217: S126-S127. DOI: 10.1016/J.Jamcollsurg.2013.07.292 |
0.376 |
|
| 2012 |
Heath CH, Deep NL, Sweeny L, Zinn KR, Rosenthal EL. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Annals of Surgical Oncology. 19: 3879-87. PMID 22669455 DOI: 10.1245/S10434-012-2435-Y |
0.375 |
|
| 2012 |
Warram JM, Sorace AG, Saini R, Borovjagin AV, Hoyt K, Zinn KR. Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles. Cancer Gene Therapy. 19: 545-52. PMID 22653385 DOI: 10.1038/Cgt.2012.29 |
0.644 |
|
| 2012 |
Kim KH, Dmitriev I, O'Malley JP, Wang M, Saddekni S, You Z, Preuss MA, Harris RD, Aurigemma R, Siegal GP, Zinn KR, Curiel DT, Alvarez RD. A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3440-51. PMID 22510347 DOI: 10.1158/1078-0432.Ccr-11-2852 |
0.341 |
|
| 2012 |
Kim H, Zhai G, Samuel SL, Rigell CJ, Umphrey HR, Rana S, Stockard CR, Fineberg NS, Zinn KR. Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma. Molecular Cancer Therapeutics. 11: 405-15. PMID 22203731 DOI: 10.1158/1535-7163.Mct-11-0581 |
0.398 |
|
| 2012 |
Oliver PG, LoBuglio AF, Zhou T, Forero A, Kim H, Zinn KR, Zhai G, Li Y, Lee CH, Buchsbaum DJ. Effect of anti-DR5 and chemotherapy on basal-like breast cancer. Breast Cancer Research and Treatment. 133: 417-26. PMID 21901385 DOI: 10.1007/S10549-011-1755-0 |
0.382 |
|
| 2012 |
Shah N, Zhai G, Knowles JA, Stockard CR, Grizzle WE, Fineberg N, Zhou T, Zinn KR, Rosenthal EL, Kim H. (18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 14: 237-44. PMID 21494920 DOI: 10.1007/S11307-011-0491-5 |
0.323 |
|
| 2012 |
Deep NL, Heath CH, Sweeny L, Zinn KR, Rosenthal EL. Imaging Cutaneous Head and Neck Cancer with Panitumumab-IRDye Otolaryngology–Head and Neck Surgery. 147: P60-P60. DOI: 10.1177/0194599812451438A76 |
0.358 |
|
| 2012 |
Vaklavas C, Meng Z, White EL, Rasmussen L, Maddry JA, Nebane-Akah M, Grizzle WE, Zinn KR, Frost AR, Stockard CR, Samuel SL, Everts M, Whitley RJ, Blume SW. Abstract 1816: Blocking synthesis of oncogenic proteins in breast tumor cells through pharmacologic inhibition of the IRES Cancer Research. 72: 1816-1816. DOI: 10.1158/1538-7445.Am2012-1816 |
0.353 |
|
| 2012 |
Sorace AG, Saini R, Mahoney M, Warram JM, Zinn KR, Hoyt K. Molecular ultrasound imaging using a novel tumor-bearing animal model with variable target receptor expression Ieee International Ultrasonics Symposium, Ius. 2049-2051. DOI: 10.1109/ULTSYM.2012.0512 |
0.633 |
|
| 2011 |
Kim H, Zhai G, Liu Z, Samuel S, Shah N, Helman EE, Knowles JA, Stockard CR, Fineberg NS, Grizzle WE, Zhou T, Zinn KR, Rosenthal EL. Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy. Anti-Cancer Drugs. 22: 864-74. PMID 21730821 DOI: 10.1097/Cad.0B013E328349311E |
0.329 |
|
| 2011 |
Warram JM, Sorace AG, Saini R, Umphrey HR, Zinn KR, Hoyt K. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 30: 921-31. PMID 21705725 DOI: 10.7863/Jum.2011.30.7.921 |
0.641 |
|
| 2011 |
Saini R, Warram JM, Sorace AG, Umphrey H, Zinn KR, Hoyt K. Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents. Ultrasound in Medicine & Biology. 37: 1306-13. PMID 21683507 DOI: 10.1016/J.Ultrasmedbio.2011.05.010 |
0.64 |
|
| 2011 |
Kim H, Folks KD, Guo L, Sellers JC, Fineberg NS, Stockard CR, Grizzle WE, Buchsbaum DJ, Morgan DE, George JF, Zinn KR. Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging. Molecular Imaging. 10: 153-67. PMID 21496446 DOI: 10.2310/7290.2010.00040 |
0.407 |
|
| 2011 |
Turk AN, Byer SJ, Zinn KR, Carroll SL. Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents. Journal of Visualized Experiments : Jove. PMID 21460792 DOI: 10.3791/2558 |
0.379 |
|
| 2011 |
Zinn KR, Anderson CJ, Bradbury M, Cutler CS, Peterson TE, Morgan DE, Price JC, Graham MM, Contag CH, Wittstrom K, Norenberg JP. Components of a curriculum for molecular imaging scientists. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 650-6. PMID 21421709 DOI: 10.2967/Jnumed.110.087064 |
0.347 |
|
| 2011 |
Byer SJ, Eckert JM, Brossier NM, Clodfelder-Miller BJ, Turk AN, Carroll AJ, Kappes JC, Zinn KR, Prasain JK, Carroll SL. Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner. Neuro-Oncology. 13: 28-41. PMID 21075781 DOI: 10.1093/Neuonc/Noq146 |
0.329 |
|
| 2011 |
Warram JM, Borovjagin AV, Zinn KR. A genetic strategy for combined screening and localized imaging of breast cancer. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 452-61. PMID 20658194 DOI: 10.1007/S11307-010-0377-Y |
0.667 |
|
| 2011 |
Kim H, Folks KD, Guo L, Stockard CR, Fineberg NS, Grizzle WE, George JF, Buchsbaum DJ, Morgan DE, Zinn KR. DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 94-103. PMID 20383593 DOI: 10.1007/S11307-010-0320-2 |
0.388 |
|
| 2011 |
Sweeny L, Zinn K, Cheng Z, Miao Z, Bishop ES, Rosenthal EL, Knowles J. Preclinical Strategies to Optimize Optical Imaging in Head and Neck Cancer Otolaryngology–Head and Neck Surgery. 145: P72-P72. DOI: 10.1177/0194599811416318A100 |
0.403 |
|
| 2011 |
Kim H, Zhai G, Shah N, Liu Z, Helman E, Knowles J, Stockard C, Grizzle W, Zhou T, Zinn K, Rosenthal E. Abstract 4575: Novel monoclonal antibody targeting EMMPRIN for pancreatic cancer therapy Cancer Research. 71: 4575-4575. DOI: 10.1158/1538-7445.Am2011-4575 |
0.33 |
|
| 2011 |
Shah N, Zhai G, Knowles J, Stockard C, Grizzle W, Fineberg N, Zhou T, Zinn K, Rosenthal E, Kim H. Abstract 1795: Therapy assessment of a novel anti-EMMPRIN antibody and gemcitabine in an orthotopic pancreatic-tumor murine model by FDG PET/CT imaging Cancer Research. 71: 1795-1795. DOI: 10.1158/1538-7445.Am2011-1795 |
0.336 |
|
| 2011 |
Kim K, Wang M, Barnes M, O'Malley J, You Z, Preuss M, Siegal G, Zinn K, Curiel D, Alvarez R. A phase I clinical trial of a novel infectivity-enhanced suicide gene adenovirus with gene transfer imaging capacity in patients with recurrent gynecologic cancer Gynecologic Oncology. 120: S31. DOI: 10.1016/J.Ygyno.2010.12.077 |
0.303 |
|
| 2010 |
Helman EE, Newman JR, Dean NR, Zhang W, Zinn KR, Rosenthal EL. Optical imaging predicts tumor response to anti-EGFR therapy. Cancer Biology & Therapy. 10: 166-71. PMID 20505368 DOI: 10.4161/Cbt.10.2.12164 |
0.414 |
|
| 2010 |
Hoyt K, Warram JM, Umphrey H, Belt L, Lockhart ME, Robbin ML, Zinn KR. Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 29: 577-85. PMID 20375376 DOI: 10.7863/Jum.2010.29.4.577 |
0.624 |
|
| 2010 |
Borovjagin AV, McNally LR, Wang M, Curiel DT, MacDougall MJ, Zinn KR. Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging. Molecular Imaging. 9: 59-75. PMID 20236604 DOI: 10.2310/7290.2010.00003 |
0.441 |
|
| 2010 |
Beck BH, Kim HG, Kim H, Samuel S, Liu Z, Shrestha R, Haines H, Zinn K, Lopez RD. Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer. Breast Cancer Research and Treatment. 122: 135-44. PMID 19763820 DOI: 10.1007/S10549-009-0527-6 |
0.348 |
|
| 2010 |
Kim H, Folks K, Guo L, Sellers J, Fineberg N, Stockard C, Grizzle W, Buchsbaum D, Morgan D, George J, Zinn K. Abstract 641: Early therapy assessment of cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging Cancer Research. 70: 641-641. DOI: 10.1158/1538-7445.Am10-641 |
0.394 |
|
| 2010 |
Saini R, Warram J, Sorace AG, Umphrey H, Zinn KR, Hoyt K. Validation of controlled receptor expression using adenoviral techniquesand targeted ultrasound imaging Proceedings - Ieee Ultrasonics Symposium. 1125-1128. DOI: 10.1109/ULTSYM.2010.5935763 |
0.6 |
|
| 2009 |
Kimball KJ, Rivera AA, Zinn KR, Icyuz M, Saini V, Li J, Zhu ZB, Siegal GP, Douglas JT, Curiel DT, Alvarez RD, Borovjagin AV. Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer. Molecular Imaging. 8: 264-77. PMID 19796604 DOI: 10.2310/7290.2009.00025 |
0.385 |
|
| 2009 |
Szafran AA, Folks K, Warram J, Chanda D, Wang D, Zinn KR. Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis. Cancer Biology & Therapy. 8: 1109-16. PMID 19652526 DOI: 10.4161/Cbt.8.12.8327 |
0.761 |
|
| 2009 |
Matthews K, Noker PE, Tian B, Grimes SD, Fulton R, Schweikart K, Harris R, Aurigemma R, Wang M, Barnes MN, Siegal GP, Hemminki A, Zinn K, Curiel DT, Alvarez RD. Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4131-7. PMID 19509153 DOI: 10.1158/1078-0432.Ccr-08-3354 |
0.323 |
|
| 2009 |
Hoyt K, Warram JM, Umphrey H, Belt L, Samuel S, Folks K, Stockard C, Lockhart M, Robbin ML, Grizzle W, Zinn KR. Assessing breast cancer response to bevacizumab using contrast-enhanced ultrasound: Initial results using a murine model Proceedings - Ieee Ultrasonics Symposium. DOI: 10.1109/ULTSYM.2009.5441595 |
0.601 |
|
| 2008 |
Kim H, Morgan DE, Buchsbaum DJ, Zeng H, Grizzle WE, Warram JM, Stockard CR, McNally LR, Long JW, Sellers JC, Forero A, Zinn KR. Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Research. 68: 8369-76. PMID 18922909 DOI: 10.1158/0008-5472.Can-08-1771 |
0.664 |
|
| 2008 |
Kim H, Morgan DE, Zeng H, Grizzle WE, Warram JM, Stockard CR, Wang D, Zinn KR. Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology. 248: 844-51. PMID 18710978 DOI: 10.1148/Radiol.2483071740 |
0.655 |
|
| 2008 |
Newman JR, Gleysteen JP, Barañano CF, Bremser JR, Zhang W, Zinn KR, Rosenthal EL. Stereomicroscopic fluorescence imaging of head and neck cancer xenografts targeting CD147. Cancer Biology & Therapy. 7: 1063-70. PMID 18431087 DOI: 10.4161/Cbt.7.7.6109 |
0.341 |
|
| 2008 |
Chanda D, Isayeva T, Kumar S, Siegal GP, Szafran AA, Zinn KR, Reddy VV, Ponnazhagan S. Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of breast cancer bone metastasis. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 871-8. PMID 18388919 DOI: 10.1038/Mt.2008.48 |
0.779 |
|
| 2008 |
Oliver PG, LoBuglio AF, Zinn KR, Kim H, Nan L, Zhou T, Wang W, Buchsbaum DJ. Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2180-9. PMID 18381960 DOI: 10.1158/1078-0432.Ccr-07-1392 |
0.398 |
|
| 2008 |
Wang X, Jiang J, Warram J, Baumann G, Gan Y, Menon RK, Denson LA, Zinn KR, Frank SJ. Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity. Molecular Endocrinology (Baltimore, Md.). 22: 1427-37. PMID 18323468 DOI: 10.1210/Me.2007-0561 |
0.603 |
|
| 2008 |
Gleysteen JP, Newman JR, Chhieng D, Frost A, Zinn KR, Rosenthal EL. Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head & Neck. 30: 782-9. PMID 18228526 DOI: 10.1002/Hed.20782 |
0.346 |
|
| 2008 |
Withrow KP, Newman JR, Skipper JB, Gleysteen JP, Magnuson JS, Zinn K, Rosenthal EL. Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts. Technology in Cancer Research & Treatment. 7: 61-6. PMID 18198926 DOI: 10.1177/153303460800700108 |
0.413 |
|
| 2008 |
Zinn KR, Chaudhuri TR, Szafran AA, O'Quinn D, Weaver C, Dugger K, Lamar D, Kesterson RA, Wang X, Frank SJ. Noninvasive bioluminescence imaging in small animals. Ilar Journal / National Research Council, Institute of Laboratory Animal Resources. 49: 103-15. PMID 18172337 DOI: 10.1093/Ilar.49.1.103 |
0.772 |
|
| 2007 |
Derosier LC, Vickers SM, Zinn KR, Huang Z, Wang W, Grizzle WE, Sellers J, Stockard CR, Zhou T, Oliver PG, Arnoletti P, Lobuglio AF, Buchsbaum DJ. TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth. Molecular Cancer Therapeutics. 6: 3198-207. PMID 18089714 DOI: 10.1158/1535-7163.Mct-07-0299 |
0.392 |
|
| 2007 |
Withrow KP, Gleysteen JP, Safavy A, Skipper J, Desmond RA, Zinn K, Rosenthal EL. Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 137: 729-34. PMID 17967636 DOI: 10.1016/J.Otohns.2007.06.736 |
0.391 |
|
| 2007 |
DeRosier LC, Buchsbaum DJ, Oliver PG, Huang ZQ, Sellers JC, Grizzle WE, Wang W, Zhou T, Zinn KR, Long JW, Vickers SM. Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5535s-5543s. PMID 17875786 DOI: 10.1158/1078-0432.Ccr-07-1075 |
0.37 |
|
| 2007 |
Gleysteen JP, Duncan RD, Magnuson JS, Skipper JB, Zinn K, Rosenthal EL. Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment. Cancer Biology & Therapy. 6: 1181-5. PMID 17637562 DOI: 10.4161/Cbt.6.8.4379 |
0.349 |
|
| 2007 |
Cowey S, Szafran AA, Kappes J, Zinn KR, Siegal GP, Desmond RA, Kim H, Evans L, Hardy RW. Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice. Clinical & Experimental Metastasis. 24: 389-401. PMID 17541709 DOI: 10.1007/S10585-007-9076-8 |
0.77 |
|
| 2007 |
Kulbersh BD, Duncan RD, Magnuson JS, Skipper JB, Zinn K, Rosenthal EL. Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Archives of Otolaryngology--Head & Neck Surgery. 133: 511-5. PMID 17520766 DOI: 10.1001/Archotol.133.5.511 |
0.362 |
|
| 2007 |
Rosenthal EL, Kulbersh BD, King T, Chaudhuri TR, Zinn KR. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts. Molecular Cancer Therapeutics. 6: 1230-8. PMID 17431103 DOI: 10.1158/1535-7163.MCT-06-0741 |
0.328 |
|
| 2007 |
Oh P, Borgström P, Witkiewicz H, Li Y, Borgström BJ, Chrastina A, Iwata K, Zinn KR, Baldwin R, Testa JE, Schnitzer JE. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nature Biotechnology. 25: 327-37. PMID 17334358 DOI: 10.1038/Nbt1292 |
0.363 |
|
| 2007 |
Liu C, Yu S, Kappes J, Wang J, Grizzle WE, Zinn KR, Zhang HG. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood. 109: 4336-42. PMID 17244679 DOI: 10.1182/Blood-2006-09-046201 |
0.337 |
|
| 2007 |
Merrell MA, Wakchoure S, Ilvesaro JM, Zinn K, Gehrs B, Lehenkari PP, Harris KW, Selander KS. Differential effects of Ca(2+) on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells. European Journal of Pharmacology. 559: 21-31. PMID 17214981 DOI: 10.1016/J.Ejphar.2006.11.064 |
0.403 |
|
| 2007 |
Kim H, Chaudhuri TR, Buchsbaum DJ, Wang D, Zinn KR. Single-photon emission computed tomography imaging with a humanized, apoptosis-inducing antibody targeting human death receptor 5 in pancreas and breast tumor xenografts Cancer Biology and Therapy. 6: 1396-1402. DOI: 10.4161/Cbt.6.9.4540 |
0.388 |
|
| 2007 |
Oh P, Borgström P, Witkiewicz H, Li Y, Borgström BJ, Chrastina A, Iwata K, Zinn KR, Baldwin R, Testa JE, Schnitzer JE. Erratum: Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung Nature Biotechnology. 25: 478-478. DOI: 10.1038/Nbt0407-478A |
0.309 |
|
| 2006 |
Rosenthal EL, Kulbersh BD, Duncan RD, Zhang W, Magnuson JS, Carroll WR, Zinn K. In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence. The Laryngoscope. 116: 1636-41. PMID 16954995 DOI: 10.1097/01.Mlg.0000232513.19873.Da |
0.314 |
|
| 2006 |
Belousova N, Harris R, Zinn K, Rhodes-Selser MA, Kotov A, Kotova O, Wang M, Aurigemma R, Zhu ZB, Curiel DT, Alvarez RD. Circumventing recombination events encountered with production of a clinical-grade adenoviral vector with a double-expression cassette. Molecular Pharmacology. 70: 1488-93. PMID 16896072 DOI: 10.1124/Mol.106.025619 |
0.312 |
|
| 2006 |
Pezold JC, Zinn K, Talbert MA, Desmond R, Rosenthal EL. Validation of ultrasonography to evaluate murine orthotopic oral cavity tumors. Orl; Journal For Oto-Rhino-Laryngology and Its Related Specialties. 68: 159-63. PMID 16465070 DOI: 10.1159/000091324 |
0.351 |
|
| 2006 |
Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia Y, Kappes JC, Barnes S, Kimberly RP, Grizzle WE, Zhang HG. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. Journal of Immunology (Baltimore, Md. : 1950). 176: 1375-85. PMID 16424164 DOI: 10.4049/Jimmunol.176.3.1375 |
0.356 |
|
| 2006 |
Rosenthal EL, Kulbersh BD, Duncan R, Magnuson JS, Zinn K. S112 Assessment of Fluorescent Immunoguided Neoplasm Detection to Identify Microscopic Disease In Vivo Archives of Otolaryngology–Head & Neck Surgery. 132: 864. DOI: 10.1001/Archotol.132.8.864-A |
0.399 |
|
| 2005 |
Buchsbaum DJ, Khazaeli MB, Axworthy DB, Schultz J, Chaudhuri TR, Zinn KR, Carpenter M, LoBuglio AF. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 8180-5. PMID 16299250 DOI: 10.1158/1078-0432.Ccr-05-0607 |
0.368 |
|
| 2005 |
Zinn KR, Wu H, Stargel A, Adams AJ, Chaudhuri TR. 448. A Genetic Strategy to Inhibit Complement Activation Arising from Adenoviral Vectors Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.456 |
0.323 |
|
| 2004 |
Chaudhuri TR, Cao Z, Ponnazhagan S, Stargel A, Simhadri PL, Zhou T, Lobuglio AF, Buchsbaum DJ, Zinn KR. Detection of disseminated breast cancer growth and treatment response using non-invasive bioluminescence imaging. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 742. PMID 28013631 DOI: 10.1200/Jco.2004.22.14_Suppl.742 |
0.301 |
|
| 2004 |
Buchsbaum DJ, Chaudhuri TR, Yamamoto M, Zinn KR. Gene expression imaging with radiolabeled peptides. Annals of Nuclear Medicine. 18: 275-83. PMID 15359919 DOI: 10.1007/Bf02984464 |
0.412 |
|
| 2004 |
Contreras JL, Chaudhuri TR, Stargel AV, Wu H, Smyth C, Bilbao G, Curiel DT, Eckhoff D, Zinn K. IN VIVO QUANTITATIVE NON-INVASIVE BIOLUMINESCENCE IMAGING OF INTRAHEPATIC TRANSPLANTED ISLETS. Transplantation. 78: 439-440. DOI: 10.1097/00007890-200407271-01176 |
0.3 |
|
| 2004 |
Zinn KR, Chaudhuri TR, Stargel A, Krasnykh V, Szalai AJ. 1013. Complement Component 3 Facilitates Ad5-Mediated Liver Transfection Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.958 |
0.318 |
|
| 2003 |
Kanerva A, Zinn KR, Chaudhuri TR, Lam JT, Suzuki K, Uil TG, Hakkarainen T, Bauerschmitz GJ, Wang M, Liu B, Cao Z, Alvarez RD, Curiel DT, Hemminki A. Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 449-58. PMID 12946318 DOI: 10.1016/S1525-0016(03)00200-4 |
0.395 |
|
| 2003 |
Xu Y, Szalai AJ, Zhou T, Zinn KR, Chaudhuri TR, Li X, Koopman WJ, Kimberly RP. Fc gamma Rs modulate cytotoxicity of anti-Fas antibodies: implications for agonistic antibody-based therapeutics. Journal of Immunology (Baltimore, Md. : 1950). 171: 562-8. PMID 12847219 DOI: 10.4049/Jimmunol.171.2.562 |
0.308 |
|
| 2003 |
Chaudhuri TR, Cao Z, Krasnykh VN, Stargel AV, Belousova N, Partridge EE, Zinn KR. Blood-based screening and light based imaging for the early detection and monitoring of ovarian cancer xenografts. Technology in Cancer Research & Treatment. 2: 171-80. PMID 12680799 DOI: 10.1177/153303460300200214 |
0.415 |
|
| 2002 |
Kim M, Zinn KR, Barnett BG, Sumerel LA, Krasnykh V, Curiel DT, Douglas JT. The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells. European Journal of Cancer (Oxford, England : 1990). 38: 1917-26. PMID 12204675 DOI: 10.1016/S0959-8049(02)00131-4 |
0.348 |
|
| 2002 |
Chaudhuri TR, Cao Z, RodrÃguez-Burford C, LoBuglio AF, Zinn KR. A non-invasive approach for monitoring breast tumor cells during therapeutic intervention. Cancer Biotherapy & Radiopharmaceuticals. 17: 205-12. PMID 12030114 DOI: 10.1089/108497802753773829 |
0.462 |
|
| 2002 |
Hemminki A, Zinn KR, Liu B, Chaudhuri TR, Desmond RA, Rogers BE, Barnes MN, Alvarez RD, Curiel DT. In vivo molecular chemotherapy and noninvasive imaging with an infectivity-enhanced adenovirus. Journal of the National Cancer Institute. 94: 741-9. PMID 12011224 DOI: 10.1093/Jnci/94.10.741 |
0.443 |
|
| 2002 |
Zinn KR, Chaudhuri TR. The type 2 human somatostatin receptor as a platform for reporter gene imaging. European Journal of Nuclear Medicine and Molecular Imaging. 29: 388-99. PMID 12002716 DOI: 10.1007/S00259-002-0764-Y |
0.39 |
|
| 2002 |
Zinn KR, Chaudhuri TR, Krasnykh VN, Buchsbaum DJ, Belousova N, Grizzle WE, Curiel DT, Rogers BE. Gamma camera dual imaging with a somatostatin receptor and thymidine kinase after gene transfer with a bicistronic adenovirus in mice. Radiology. 223: 417-25. PMID 11997547 DOI: 10.1148/Radiol.2232010501 |
0.392 |
|
| 2002 |
Rogers BE, Zinn KR, Lin CY, Chaudhuri TR, Buchsbaum DJ. Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector. Cancer. 94: 1298-305. PMID 11877760 DOI: 10.1002/Cncr.10300 |
0.308 |
|
| 2001 |
Chaudhuri TR, Rogers BE, Buchsbaum DJ, Mountz JM, Zinn KR. A noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts. Gynecologic Oncology. 83: 432-8. PMID 11606113 DOI: 10.1006/Gyno.2001.6333 |
0.419 |
|
| 2001 |
Hemminki A, Belousova N, Zinn KR, Liu B, Wang M, Chaudhuri TR, Rogers BE, Buchsbaum DJ, Siegal GP, Barnes MN, Gomez-Navarro J, Curiel DT, Alvarez RD. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 4: 223-31. PMID 11545613 DOI: 10.1006/Mthe.2001.0446 |
0.365 |
|
| 2001 |
Chaudhuri TR, Mountz JM, Rogers BE, Partridge EE, Zinn KR. Light-based imaging of green fluorescent protein-positive ovarian cancer xenografts during therapy. Gynecologic Oncology. 82: 581-9. PMID 11520161 DOI: 10.1006/Gyno.2001.6297 |
0.43 |
|
| 2001 |
Zinn KR, Chaudhuri TR, Buchsbaum DJ, Mountz JM, Rogers BE. Detection and measurement of in vitro gene transfer by gamma camera imaging. Gene Therapy. 8: 291-9. PMID 11313803 DOI: 10.1038/Sj.Gt.3301391 |
0.393 |
|
| 2001 |
Zinn KR, Chaudhuri TR, Buchsbaum DJ, Mountz JM, Rogers BE. Simultaneous evaluation of dual gene transfer to adherent cells by gamma-ray imaging. Nuclear Medicine and Biology. 28: 135-44. PMID 11295424 DOI: 10.1016/S0969-8051(00)00207-9 |
0.368 |
|
| 2000 |
Reynolds PN, Zinn KR, Gavrilyuk VD, Balyasnikova IV, Rogers BE, Buchsbaum DJ, Wang MH, Miletich DJ, Grizzle WE, Douglas JT, Danilov SM, Curiel DT. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 2: 562-78. PMID 11124057 DOI: 10.1006/Mthe.2000.0205 |
0.325 |
|
| 1998 |
Zinn KR, Douglas JT, Smyth CA, Liu HG, Wu Q, Krasnykh VN, Mountz JD, Curiel DT, Mountz JM. Imaging and tissue biodistribution of 99mTc-labeled adenovirus knob (serotype 5). Gene Therapy. 5: 798-808. PMID 9747460 DOI: 10.1038/Sj.Gt.3300659 |
0.341 |
|
| 1994 |
Chaudhuri TR, Zinn KR, Morris JS, McDonald GA, Llorens AS, Chaudhuri TK. Human monoclonal antibody developed against ovarian cancer cell surface antigen. Cancer. 73: 1098-104. PMID 8306253 DOI: 10.1002/1097-0142(19940201)73:3+<1098::Aid-Cncr2820731350>3.0.Co;2-A |
0.325 |
|
| Show low-probability matches. |